Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Diversification is a key tool to dampen volatility in retirement portfolios. This note outlines practical allocation strategies and real-world scenarios.
26,772 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Two popular funds offer distinct approaches to U.S. financials. This guide breaks down cost, diversification, and str...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
As Flowers Foods eyes 2026, investors want a clear view of how the bread business can weather inflation and shifting ...
IBP's Q1 2026 results set the tone for the year. This original analysis breaks down the numbers, margins, and guidanc...
When new Berkshire leadership takes the reins, investors wonder which names could ride along. Here’s why a flavor-foc...
A big fund trimmed its ACMR stake, yet the stock jumped 170% in a short window. This article breaks down what happene...
A stock trading earnings at a strikingly low multiple sits quietly in many portfolios. This article breaks down how t...
United Airlines will cut about 5% of capacity this quarter as jet fuel prices climb amid geopolitical tensions. The m...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...
Meta is dialing back its grand metaverse bet. This pivot could reshape the company’s profits and the stock’s long-run...